Section 01About Glyca
Glyca is a registered company that develops, manufactures and markets clinical-grade peptides and wellness products. We operate in full compliance with the applicable law and with international industry good practice.
Glyca:
—Develops and manufactures all products in its own certified facilities
—Submits every product to purity and quality testing by an accredited independent laboratory
—Provides a Certificate of Analysis (CoA) for every batch produced
—Makes no therapeutic or medicinal claims about its products
—Operates exclusively in the research and personal wellness segment
—Maintains full traceability from raw material through to the finished product delivered to the customer
Business model — direct manufacturer
Glyca is not a pharmacy, a licensed pharmaceutical company or a healthcare provider, and does not operate as a third-party intermediary. We are direct manufacturers and marketers of research compounds and wellness products.
All Glyca products:
—Are developed and produced in-house in GMP certified facilities
—Are sold exclusively for research, educational and personal wellness purposes
—Are not licensed as medicinal products under the applicable therapeutic products legislation or any other pharmaceutical law, unless expressly stated otherwise
—Are accompanied by complete and traceable quality documentation
Responsibility for the regulatory compliance of the products rests entirely with Glyca, in its capacity as manufacturer.
Section 03Quality and manufacturing policy
3.1 Certifications and manufacturing standards
—Production facilities certified to Good Manufacturing Practice (GMP)
—Compliance with the guidelines of the competent therapeutic products authority
—In-house quality control at every stage of the production process
—Full traceability of raw materials and production batches
3.2 Independent laboratory testing
—Every batch is analysed by an independent, accredited third-party laboratory
—High-Performance Liquid Chromatography (HPLC) testing for purity verification
—Certificates of Analysis (CoA) made available for public consultation on our website
—Zero-tolerance policy for batches that fail to meet the minimum purity criteria
3.3 Traceability
—Every product carries a unique batch number and a traceable expiry date
—Production and quality records kept for a minimum of 10 years
—Product recall system in place in the event that a non-conformity is identified
Product compliance framework
4.1 Research and wellness classification
All Glyca products are classified and marketed exclusively as research compounds or personal wellness products. No product is presented, described or sold as a licensed medicine or a prescription drug.
4.2 No therapeutic claims
Glyca makes no claims of diagnosis, treatment, cure or prevention of disease in relation to any product. All product descriptions are based on publicly available scientific literature and do not constitute medical advice.
4.3 Labelling compliance
All Glyca products carry complete labelling with:
—Accurate identification of the compound
—Concentration and dosage information
—Batch number and expiry date
—Storage and handling instructions
—A clear “For Research & Wellness Only” designation
4.4 No off-label promotion
Glyca does not promote, suggest or imply any off-label use of its products. All marketing communication complies with the applicable guidelines on the advertising of wellness products.
Section 05Age verification and consumer protection
—All purchases on the Glyca platform require the customer to confirm that they are 18 years of age or older
—Glyca reserves the right to request proof of age and to cancel any order where such verification cannot be confirmed
—Under no circumstances do we sell to minors
—Orders suspected of being placed by or on behalf of a minor will be cancelled and refunded
Data protection compliance
Glyca operates in full compliance with the applicable data protection legislation and, where applicable, with the General Data Protection Regulation (GDPR) of the European Union.
—We are registered as data controllers with the competent authorities
—Customer data is collected, stored and processed lawfully, transparently and for specified purposes
—We do not sell, rent or share personal data with third parties for marketing purposes
—Full details are set out in our Privacy Policy, available at glycapharma.com
Anti-counterfeiting and authenticity
Glyca takes the authenticity of its products very seriously. To protect our customers:
—All products are manufactured in our own certified facilities. We do not use unverified contract manufacturing
—Every batch has a CoA from an accredited independent laboratory available for consultation
—We cooperate actively with regulatory authorities and law enforcement in any investigation relating to product authenticity
Intellectual property compliance
—Glyca respects all intellectual property rights and does not market products that infringe third-party patents, trademarks or trade secrets
—All brand names, product names and trademarks shown on our platform belong to their respective owners
—Glyca operates independently and is not affiliated with, sponsored by, or acting as agent for any pharmaceutical company
—If you believe any product or content on our platform infringes your intellectual property rights, contact info@glycapharma.com and we will investigate promptly Third-party claims and legal notices
Glyca operates in good faith and in full compliance with the applicable law. In the event of a claim or legal notice from a third party, including pharmaceutical companies, regulatory bodies or private individuals:
—We undertake to acknowledge receipt of all formal notices within 5 business days
—We will cooperate fully with any legitimate regulatory investigation
—We maintain complete records of all production documentation, product listings and transaction histories
—Our legal position is that we operate as a direct manufacturer of research compounds and wellness products, in compliance with the applicable law, and do not carry on licensed pharmaceutical activity
Glyca is not subject to enforcement action relating to the distribution of prescription-only or unlicensed medicines, as such activities do not form part of our business model.
Section 10Regulatory framework — jurisdiction notice
Glyca is incorporated and operates under the law of its country of registration. Our compliance framework has been designed in accordance with the applicable statutes listed below.
To be confirmed · jurisdiction
The source document lists the Swiss framework: Swissmedic guidelines, the Federal Act on Medicinal Products (TPA), the revised Federal Act on Data Protection (revFADP), the Federal Act against Unfair Competition (UCA), the applicable federal consumer protection law, and the EU GDPR where applicable. Confirm Glyca’s country of registration and replace this block with the correct list of statutes.
Customers outside that jurisdiction are solely responsible for ensuring that their purchase and use of any product complies with the laws of their own jurisdiction. Glyca makes no representation as to the legal status of any product in jurisdictions other than its own.
